Kura Oncology Inc
General ticker "KURA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $898.1M
Kura Oncology Inc does not follow the US Stock Market performance with the rate: -5.0%.
Estimated limits based on current volatility of 1.7%: low 8.82$, high 9.31$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [8.05$, 18.63$]
- 2024-12-30 to 2025-12-30 estimated range: [9.72$, 21.11$]
Financial Metrics affecting the KURA estimates:
- Negative: Non-GAAP EPS, $ of -2.08 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -13.08 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Investing cash flow per share, $ of 0.21 > -0.12
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
Short-term KURA quotes
Long-term KURA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.16MM | $2.04MM | $0.00MM |
| Operating Expenses | $131.67MM | $140.09MM | $165.80MM |
| Operating Income | $-131.51MM | $-138.06MM | $-165.80MM |
| Non-Operating Income | $0.00MM | $0.00MM | $13.17MM |
| Interest Expense | $0.41MM | $0.23MM | $1.55MM |
| R&D Expense | $84.72MM | $92.81MM | $115.23MM |
| Income(Loss) | $-131.51MM | $-138.06MM | $-152.63MM |
| Profit(Loss) | $-131.51MM | $-138.06MM | $-152.63MM |
| Stockholders Equity | $506.61MM | $420.28MM | $397.27MM |
| Assets | $534.05MM | $456.31MM | $448.94MM |
| Operating Cash Flow | $-104.55MM | $-110.06MM | $-124.82MM |
| Capital expenditure | $1.15MM | $0.63MM | $0.17MM |
| Investing Cash Flow | $-126.83MM | $32.63MM | $15.56MM |
| Financing Cash Flow | $-3.44MM | $38.56MM | $94.78MM |
| Earnings Per Share* | $-1.96 | $-2.03 | $-2.08 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.